Targeting the EGFR signaling pathway in cancer therapy

P Seshacharyulu, MP Ponnusamy… - Expert opinion on …, 2012 - Taylor & Francis
Introduction: Cancer is a devastating disease; however, several therapeutic advances have
recently been made, wherein EGFR and its family members have emerged as useful …

Cancer-associated mucins: role in immune modulation and metastasis

R Bhatia, SK Gautam, A Cannon, C Thompson… - Cancer and Metastasis …, 2019 - Springer
Mucins (MUC) protect epithelial barriers from environmental insult to maintain homeostasis.
However, their aberrant overexpression and glycosylation in various malignancies facilitate …

Mucins in cancer: function, prognosis and therapy

DW Kufe - Nature Reviews Cancer, 2009 - nature.com
Epithelia are protected from adverse conditions by a mucous barrier. The secreted and
transmembrane mucins that constitute the mucous barrier are largely unrecognized as …

Tumor necrosis factor α blockade: an opportunity to tackle breast cancer

MF Mercogliano, S Bruni, PV Elizalde… - Frontiers in …, 2020 - frontiersin.org
Breast cancer is the most frequently diagnosed cancer and the principal cause of mortality
by malignancy in women and represents a main problem for public health worldwide. Tumor …

Altered glycosylation in pancreatic cancer and beyond

JC Lumibao, JR Tremblay, J Hsu… - Journal of Experimental …, 2022 - rupress.org
Pancreatic ductal adenocarcinoma (PDA) is one of the deadliest cancers and is projected to
soon be the second leading cause of cancer death. Median survival of PDA patients is 6–10 …

Mucins in pancreatic cancer and its microenvironment

S Kaur, S Kumar, N Momi, AR Sasson… - Nature reviews …, 2013 - nature.com
Pancreatic cancer remains a lethal malignancy with poor prognosis owing to therapeutic
resistance, frequent recurrence and the absence of treatment strategies that specifically …

Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells

S Bafna, S Kaur, SK Batra - Oncogene, 2010 - nature.com
Mucins (MUC) are high molecular weight O-linked glycoproteins whose primary functions
are to hydrate, protect, and lubricate the epithelial luminal surfaces of the ducts within the …

MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma

LA Doyle, E Möller, P Dal Cin… - The American journal …, 2011 - journals.lww.com
Low-grade fibromyxoid sarcoma (LGFMS) is a distinctive fibroblastic neoplasm that is
characterized by alternating collagenous and myxoid areas, deceptively bland spindle cell …

MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement

LA Doyle, WL Wang, P Dal Cin… - The American journal …, 2012 - journals.lww.com
Sclerosing epithelioid fibrosarcoma (SEF) is a rare aggressive fibroblastic neoplasm
composed of cords of epithelioid cells embedded in a dense collagenous stroma. The …

Mucins in the pathogenesis of breast cancer: implications in diagnosis, prognosis and therapy

P Mukhopadhyay, S Chakraborty… - … et Biophysica Acta (BBA …, 2011 - Elsevier
Mucins are high molecular weight, multifunctional glycoproteins comprised of two structural
classes—the large transmembrane mucins and the gel-forming or secreted mucins. The …